Thelansis

Fragile X Syndrome (FXS) Market Outlook Thelansis’s “Fragile X Syndrome (FXS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fragile X Syndrome (FXS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s tra...

Fragile X Syndrome (FXS) Market Outlook Thelansis’s “Fragile X Syndrome (FXS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fragile X Syndrome (FXS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Fragile X Syndrome (FXS) Overview Fragile X syndrome (FXS) is a rare genetic disorder with a wide range of symptoms, affecting both males and females. In males, it typically manifests in childhood with delayed development, varying degrees of intellectual deficits, and potential behavioral issues. These behaviors can range from mild anxiety and mood swings to more severe problems like aggression and autism-like traits such as hand fl...

  Fragile X syndrome (FXS) is a rare genetic disorder with a wide range of symptoms, affecting both males and females. In males, it typically manifests in childhood with delayed development, varying degrees of intellectual deficits, and potential behavioral issues. These behaviors can range from mild anxiety and mood swings to more severe problems like aggression and autism-like traits such as hand flapping and gaze avoidance. In contrast, females usually experience milder intellectual and behavioral challenges, often marked by shyness and social anxiety. The underlying cause of FXS is the silencing of the FMR1 gene on the X chromosome, primarily due to the expansion and methylation of CGG trinucleotide repeats in its 5'-untranslated region. This gene codes for the FMRP protein, which regulates protein synthesis in neurons, impacting synaptic plasticity in various brain regions, including the hippocampus. Physical features associated with FXS include a high forehead, large ears, hy...